Israeli Microdosing Cannabis Inhaler Receives Approval In Canada
The real-world data of the trials showed that patients experienced a 90% reduction in adverse effects associated with marijuana use in comparison with other methods such as oil, smoking, and vaping.
Syqe® Receives Health Canada Approval For Medical Cannabis Inhaler
Studies show the low-dose, smokeless device is effective at treating chronic pain without psychoactive effects.
Israeli Medical Cannabis Inhaler Gets Canada’s Marketing Nod
Approval is the first by an international regulator allowing the marketing of a precisely dosed cannabis inhaler as a medical product, Syqe® Medical says.
This Israeli Revolutionized Medical Cannabis Once. Now He’s Doing It Again
Perry Davidson’s Syqe® Medical has begun selling a medical cannabis inhaler that ensures that each patient is administered an exact dosage.
Eight Years And $83 Million Later, Syqe® Medical Releases First Cannabis Inhaler
Teva will market the company’s inhalers exclusively in Israel, after signing a marketing and distribution agreement with Syqe® in 2016.
Syqe® Begins Marketing Medical Cannabis Inhaler
The new inhaler, which allows doctors to prescribe precise dosages, has received Ministry of Health approval in Israel.
Cannabis Inhaler Company Syqe® Medical Raises $50 Million
Syqe® develops a pocket-sized metered-dose inhaler designed for precise delivery of cannabis molecules.
How Israel’s Weed Tech Industry Is Taking On America’s Opioid Crisis
America is beginning to see cannabis as an alternative to prescription pills. Israel is years ahead – and its entrepreneurs want to curb a crisis of opioid addiction that is completely out of control.
